TWD 15.35
(-21.48%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -365.41 Million TWD | -829.2% |
2022 | -39.32 Million TWD | 71.74% |
2021 | -139.17 Million TWD | -851.42% |
2020 | 18.52 Million TWD | 150.77% |
2019 | -36.48 Million TWD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 148.35 Million TWD | 0.0% |
2024 Q1 | 148.35 Million TWD | 140.6% |
2023 Q2 | -24.31 Million TWD | 46.61% |
2023 Q1 | -45.53 Million TWD | -15.78% |
2023 Q3 | -384.64 Million TWD | -1482.13% |
2023 FY | -365.41 Million TWD | -829.2% |
2023 Q4 | -365.41 Million TWD | 5.0% |
2022 Q3 | -60.9 Million TWD | 0.0% |
2022 Q4 | -39.32 Million TWD | 35.43% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -374.299% |
SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | -38.328% |
Level Biotechnology Inc. | -453.9 Million TWD | 19.494% |
Sagittarius Life Science Corp | -120.57 Million TWD | -203.076% |
NeoCore Technology Co., Ltd. | -196.39 Million TWD | -86.061% |
TaiMed Biologics Inc. | 499.84 Million TWD | 173.106% |
GlycoNex Incorporation | -148.56 Million TWD | -145.962% |
VBI | -25.31 Million TWD | -1343.431% |
GeneReach Biotechnology Corp. | 40.26 Million TWD | 1007.513% |
Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 364.806% |
SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | -39.164% |
Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 1295.039% |
Visgeneer Inc. | 31.28 Million TWD | 1268.07% |
Mycenax Biotech Inc. | 207 Million TWD | 276.523% |
Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 46.31% |
G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | -172.189% |
Neith Corporation | -150.31 Million TWD | -143.109% |
Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 158.793% |
TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -533.77% |
Enimmune corporation | -314.15 Million TWD | -16.317% |
TaiRx, Inc. | -147.86 Million TWD | -147.123% |
CHO Pharma, Inc. | -203.79 Million TWD | -79.31% |
EirGenix Inc. | -4.58 Billion TWD | 92.035% |
BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -331.107% |
Sunny Pharmtech Inc. | 120.87 Million TWD | 402.321% |
Lin BioScience, Inc. | -3.21 Billion TWD | 88.645% |
BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | -15.122% |
Feng Chi Biotech Corp. | -19.81 Million TWD | -1744.34% |
Bio Preventive Medicine Corp. | 31.8 Million TWD | 1248.791% |
Lukas Biomedical Inc. | 50.75 Million TWD | 819.967% |
RBC Bioscience Corporation | 422.18 Million TWD | 186.554% |
BiOptic Inc. | 12.59 Million TWD | 3001.993% |
BRIM Biotechnology, Inc. | -944.4 Million TWD | 61.307% |
Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -260.068% |
Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | -121.23% |
Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 216.053% |
Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -468.118% |
NaviFUS Corp. | -123.12 Million TWD | -196.777% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 593.469% |
Sinew Pharma Inc. | -160.34 Million TWD | -127.895% |
Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | -51.066% |
Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | -8.313% |
Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 11.443% |
AP Biosciences Inc | -196.52 Million TWD | -85.937% |
Medigen Biotechnology Corp. | 688.73 Million TWD | 153.056% |
3D Global Biotech Inc. | -11.43 Million TWD | -3095.06% |
Pharmosa Biopharm Inc. | -829.69 Million TWD | 55.957% |
Intech Biopharm Corporation | 1.35 Billion TWD | 126.922% |
Oneness Biotech Co., Ltd. | -414.87 Million TWD | 11.921% |
Eusol Biotech Co.,Ltd. | -209.33 Million TWD | -74.559% |
TWi Biotechnology, Inc. | -143.86 Million TWD | -154.005% |
Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | -10.551% |
TCI GENE Inc. | -689.25 Million TWD | 46.983% |
MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -207.235% |
Senhwa Biosciences, Inc. | -1.3 Billion TWD | 72.089% |
Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 1884.011% |
NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -258.711% |
PharmaEngine, Inc. | -860.8 Million TWD | 57.549% |
Savior Lifetec Corporation | -812.54 Million TWD | 55.028% |
TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | -21.819% |
OBI Pharma, Inc. | -398.22 Million TWD | 8.238% |
Acepodia, Inc. | -6.02 Billion TWD | 93.93% |
Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 89.258% |